Live Breaking News & Updates on Clonal Ready Gene Fragments

Stay updated with breaking news from Clonal ready gene fragments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results

Search jobs
Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results
SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) #DNA Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020.
“We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We see early evidence that our investment in synbio products for our pharmaceutical and biotech customers is beginning to gain traction, and for our NGS tools business, our liquid biopsy customers continue to drive revenue growth. Both our biopharma and DNA data storage teams made progress in advancing technologies, and we strengthened our balance sheet with ....

United States , Emilym Leproust , Jim Thorburn , Aaron Sato , Paula Green , Siyuan Chen , Facebook Linkedin Youtube , Bioscience Corporation , Us Centers For Disease , Cell Technology , Twist Bioscience Corporation , Development Expenses , Exchange Commission , Corporate Affairs , Administrative Expenses , First Quarter , Clonal Ready Gene Fragments , Gene Fragments , Gene Fragment , Disease Control , Multiplex Assay , Twist Biopharma , Chimeric Antigen Receptors , Applied Stemcell , Angela Bitting , Ginkgo Bioworks ,

Twist Bioscience Plans to Bring 400 Jobs to Oregon with New State-of-the-Art Facility

Published: Dec 23, 2020
By Brandon May
San Francisco, Calif.-based
Twist Bioscience announced it plans to expand its manufacturing and commercial capabilities by establishing a new facility outside of Portland, Oregon. The company expects this expansion to bring nearly 400 jobs to the Portland region once it becomes operational some time in 2022.
The new state-of-the-art facility, dubbed the “Factory of the Future,” will span 110,000 square feet and will be located in the city of Wilsonville, Oregon.
“The Portland area is an established technology hub relatively close in proximity to our headquarters with a growing number of biotechnology companies, providing access to talent and advanced manufacturing to increase the speed of production and deliver products to our customers faster,” Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, said in a ....

United States , San Francisco , Emilym Leproust , Twist Bioscienceannounced , Twist Bioscience , North America , Clonal Ready Gene Fragments , Infectious Disease Week , Twist Bioscience Plans To Bring 400 Jobs Oregon With New State Of The Art Facility , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , திருப்பம் உயிர் அறிவியல் , வடக்கு அமெரிக்கா , தொற்று நோய் வாரம் , திருப்பம் உயிர் அறிவியல் திட்டங்கள் க்கு கொண்டு வாருங்கள் வேலைகள் ஓரிகந் உடன் புதியது நிலை ஆஃப் தி கலை வசதி ,